Trial intelligence / Profile preview

Independent and safe patient decision-making for use of Tadalafil Polpharma 10 mg in erectile dysfunction

2020-002731-30Phase 4Active

Sponsor
Polpharma
Start
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of tadalafil in erectile dysfunction (ED), sponsored by Polpharma. Started Jul 2020; status: active.

02

Drugs

tadalafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on 2020-002731-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-002731-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call